review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1090385949 |
P356 | DOI | 10.1007/S10549-017-4367-5 |
P698 | PubMed publication ID | 28689362 |
P50 | author | Benjamin C Calhoun | Q54432630 |
P2093 | author name string | Chirag Shah | |
Halle C F Moore | |||
Rahul D Tendulkar | |||
Shree Agrawal | |||
Camille A Berriochoa | |||
C Marc Leyrer | |||
Robyn Stewart | |||
Alana Donaldson | |||
P2860 | cites work | Cancer statistics, 2016 | Q29547383 |
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Q29619481 | ||
Review of metaplastic carcinoma of the breast: imaging findings and pathologic features | Q30467441 | ||
Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base | Q31070408 | ||
Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center | Q35675665 | ||
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study | Q35677292 | ||
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature | Q36606990 | ||
Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators | Q36922205 | ||
Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy | Q38359372 | ||
Metaplastic carcinoma of the breast | Q38510550 | ||
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma | Q38819961 | ||
Management and Outcomes in Metaplastic Breast Cancer | Q38840364 | ||
Immunoprofile of metaplastic carcinomas of the breast. | Q39059326 | ||
A Case of Metaplastic Carcinoma of the Breast Responsive to Chemotherapy with Ifosfamide and Etoposide: Improved Antitumor Response by Targeting Sarcomatous Features | Q42821813 | ||
Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer | Q43167779 | ||
Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis | Q43538433 | ||
The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma | Q44366480 | ||
Metaplastic carcinomas of the breast. II. Spindle cell carcinoma | Q44656970 | ||
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era. | Q51018842 | ||
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. | Q54615889 | ||
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 499-504 | |
P577 | publication date | 2017-07-08 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Predictive factors on outcomes in metaplastic breast cancer | |
P478 | volume | 165 |